Cyanotech

NutraWomen Wednesday: Collette Kakuk, Chief Strategic and Commercial Officer, Cyanotech

11-Oct-2023 By Danielle Masterson

With an impressive background in business development, strategy and marketing as well as a passion for people, animals, and the planet, Collette Kakuk, Cyanotech’s Chief Strategic and Commercial Officer, wants to see sustainability up close and personal.

Bad weather deflates Cyanotech's earnings

12-Jul-2016 By Hank Schultz

Bad weather that damaged algae production significantly depressed Cyanotech’s earnings performance in 2016, the company announced recently.

Special edition: Antioxidants and carotenoids

Astaxanthin: Still red hot or cooling off? The Dr Oz effect… two years on

15-Mar-2013 By Elaine WATSON

Rewind two years, and astaxanthin was the hottest nutraceutical in town, with sales “skyrocketing” following a slot on Dr Oz in which Dr Joseph Mercola described the potent red antioxidant as the “number one supplement you’ve never heard of that you should...

Valensa on astaxanthin dispute with Cyanotech: ‘It is disappointing it has come to this’

18-Jul-2012 By Elaine Watson

It is “disappointing” that two key players in the astaxanthin market have ended up talking via their attorneys after their “excellent business relationship” became frayed, Valensa International president Dr Rudi Moerck has admitted.

Astaxanthin wars: Cyanotech and Valensa row over competition, IP

02-Jul-2012 By Elaine Watson

Hawaii-based microalgae specialist Cyanotech and Florida-based nutraceutical firm US Nutraceuticals (doing business as Valensa International) have become embroiled in a bitter legal dispute over the potent red antioxidant astaxanthin.

Cyanotech reports surge in Q3 profits on back of ‘exceptional growth’ in astaxanthin

09-Feb-2012 By Elaine Watson

Hawaii-based microalgae specialist Cyanotech has posted a surge in third quarter net income driven by "exceptional growth" in sales of the potent red antioxidant astaxanthin.

Cyanotech ups astaxanthin capacity by 33% as demand continues to soar

13-Oct-2011 By Elaine Watson

Hawaii-based microalgae specialist Cyanotech is expanding its astaxanthin capacity by a third to meet growing demand for the potent red antioxidant.

FDA passes 12 mg New Dietary Ingredient petition for astaxanthin

16-Sep-2011 By Stephen Daniells

The US Food and Drug Administration (FDA) has issued permission for an increase in the daily serving for astaxanthin from 7.8 mg to 12 mg, following a successful petition by Cyanotech.

Cyanotech to hike all prices

18-Aug-2008 By Lorraine Heller

Microalgae supplier Cyanotech has said it plans to increase prices of its full range of ingredients as it can no longer offset the rising input costs to the business.

Astaxanthin softens sales blow for Cyanotech

13-Feb-2006 By Jess Halliday

Astaxanthin for human nutrition is still a saving grace for
Cyanotech, which has reported that a 27 percent drop in sales for
3Q 2006 compared to the prior year period are down to reduced
orders for spirulina and for NatuRose aquaculture...

Cyanotech counts on China for astaxanthin expansion

11-Jan-2006 By Jess Halliday

Cyanotech has signed a deal with a distribution company in China
that will see its astaxanthin ingredient sold in the promising
market for the first time - for both human nutrition and
aquaculture.

Cyanotech receives Nasdaq delisting warning

07-Dec-2005 By Staff Reporter

Cyanotech has been threatened with being bumped from Nasdaq's
SmallCap market if its share price does not rise above the minimum
$1.00 for 10 consecutive days before the end of May 2006.

Cyanotech and Earthrise request spirulina toxin test

27-Apr-2005

Microalgae producers Cyanotech and Earthrise Nutritionals have
signaled their surprise that spirulina was excluded from a recent
study suggesting that a potential toxin known as BMAA is present in
diverse groups of cyanobacteria,...

Bad weather dampens Cyanotech's Q1 sales

03-Aug-2004

The Hawaiian based nutraceutical firm Cyanotech - which makes
natural products from microalgae - has announced a shaky start to
fiscal 2005, despite a recent return to profitability.

Cyanotech supplement to fight CTS

10-May-2002

Natural astaxanthin produced from algae can help reduce the
symptoms of Carpal Tunnel Syndrome, the ailment also known as
repetitive stress injury which affects users of computers and cash
registers, reports the Hawaii-based group...